292 related articles for article (PubMed ID: 34870334)
1. Clinical Features of Parosmia Associated With COVID-19 Infection.
Lerner DK; Garvey KL; Arrighi-Allisan AE; Filimonov A; Filip P; Shah J; Tweel B; Del Signore A; Schaberg M; Colley P; Govindaraj S; Iloreta AM
Laryngoscope; 2022 Mar; 132(3):633-639. PubMed ID: 34870334
[TBL] [Abstract][Full Text] [Related]
2. Qualitative Olfactory Dysfunction and COVID-19: An Evidence-Based Review with Recommendations for the Clinician.
Gary JB; Gallagher L; Joseph PV; Reed D; Gudis DA; Overdevest JB
Am J Rhinol Allergy; 2023 Jan; 37(1):95-101. PubMed ID: 35957578
[TBL] [Abstract][Full Text] [Related]
3. Olfactory-related Quality of Life Adjustments in Smell Loss during the Coronavirus-19 Pandemic.
Liu DT; Prem B; Besser G; Renner B; Mueller CA
Am J Rhinol Allergy; 2022 Mar; 36(2):253-260. PubMed ID: 34704454
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and associated factors of qualitative olfactory dysfunction.
Eo TS; Lee HY; Cho HJ; Yoon JH; Rha MS; Kim CH
Rhinology; 2023 Oct; 61(5):432-440. PubMed ID: 37243721
[TBL] [Abstract][Full Text] [Related]
5. Modified Olfactory Training Is an Effective Treatment Method for COVID-19 Induced Parosmia.
Altundag A; Yilmaz E; Kesimli MC
Laryngoscope; 2022 Jul; 132(7):1433-1438. PubMed ID: 35257391
[TBL] [Abstract][Full Text] [Related]
6. A longitudinal study of olfactory dysfunction and parosmia in mild COVID-19 cases.
Monk AS; Bacon DR; Onuorah P; Murr A; Wiesen CA; Oakes J; Thorp BD; Ebert CS; Wohl D; Senior BA; Kimple AJ
Rhinol Online; 2022; 5():168-172. PubMed ID: 37008801
[TBL] [Abstract][Full Text] [Related]
7. Implementing a COVID-19 specialist smell clinic: experience at the Wrightington, Wigan and Leigh Teaching Hospitals (WWL), NHS Foundation Trust, United Kingdom.
Chu M; Gopikrishna D; Rocke J; Kumar BN
Med J Malaysia; 2021 Aug; 76(Suppl 4):9-13. PubMed ID: 34558550
[TBL] [Abstract][Full Text] [Related]
8. Patterns and clinical outcomes of olfactory and gustatory disorders in six months: Prospective study of 1031 COVID-19 patients.
Teaima AA; Salem OM; Teama MAEM; Mansour OI; Taha MS; Badr FM; Khater SS; Abdou K; Mahmoud MS
Am J Otolaryngol; 2022; 43(1):103259. PubMed ID: 34626912
[TBL] [Abstract][Full Text] [Related]
9. Stellate ganglion block for treating post-COVID-19 parosmia.
Naimi BR; Garvey E; Chandna M; Duffy A; Hunter SR; Mandloi S; Kahn C; Farquhar D; D'Souza G; Rabinowitz M; Rosen M; Toskala E; Roedl JB; Zoga A; Nyquist G; Rosen D
Int Forum Allergy Rhinol; 2024 Jun; 14(6):1088-1096. PubMed ID: 38226898
[TBL] [Abstract][Full Text] [Related]
10. Clinical Features in Russian Patients with COVID-Associated Parosmia/Phanthosmia.
Kopishinskaia S; Lapshova D; Sherman M; Velichko I; Voznesensky N; Voznesenskaia V
Psychiatr Danub; 2021 Sep; 33(Suppl 9):130-136. PubMed ID: 34559791
[TBL] [Abstract][Full Text] [Related]
11. Clinical factors associated with lower health scores in COVID-19-related persistent olfactory dysfunction.
Said M; Luong T; Jang SS; Davis ME; DeConde AS; Yan CH
Int Forum Allergy Rhinol; 2022 Oct; 12(10):1242-1253. PubMed ID: 35032409
[TBL] [Abstract][Full Text] [Related]
12. Proof-of-concept: SCENTinel 1.1 rapidly discriminates COVID-19-related olfactory disorders.
Hunter SR; Hannum ME; Pellegrino R; O'Leary MA; Rawson NE; Reed DR; Dalton PH; Parma V
Chem Senses; 2023 Jan; 48():. PubMed ID: 36796784
[TBL] [Abstract][Full Text] [Related]
13. Long-lasting olfactory dysfunction in COVID-19 patients.
Prem B; Liu DT; Besser G; Sharma G; Dultinger LE; Hofer SV; Matiasczyk MM; Renner B; Mueller CA
Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3485-3492. PubMed ID: 34757458
[TBL] [Abstract][Full Text] [Related]
14. In Response to Clinical Features of Parosmia Associated with COVID-19 Infection.
Vaira LA; De Riu G; Salzano G; Maglitto F; Boscolo-Rizzo P; Lechien JR
Laryngoscope; 2022 Jul; 132(7):E28-E29. PubMed ID: 35385148
[No Abstract] [Full Text] [Related]
15. Coronavirus disease 2019 related parosmia: an exploratory survey of demographics and treatment strategies.
Sowerby LJ; Almubarak Z; Biadsee A; Rocha T; Hopkins C
J Laryngol Otol; 2023 Nov; 137(11):1256-1260. PubMed ID: 37194063
[TBL] [Abstract][Full Text] [Related]
16. Distorted chemosensory perception and female sex associate with persistent smell and/or taste loss in people with SARS-CoV-2 antibodies: a community based cohort study investigating clinical course and resolution of acute smell and/or taste loss in people with and without SARS-CoV-2 antibodies in London, UK.
Makaronidis J; Firman C; Magee CG; Mok J; Balogun N; Lechner M; Carnemolla A; Batterham RL
BMC Infect Dis; 2021 Feb; 21(1):221. PubMed ID: 33632171
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and 24-month recovery of olfactory dysfunction in COVID-19 patients: A multicentre prospective study.
Lechien JR; Vaira LA; Saussez S
J Intern Med; 2023 Jan; 293(1):82-90. PubMed ID: 36000469
[TBL] [Abstract][Full Text] [Related]
18. Platelet-rich plasma injection in the olfactory clefts of COVID-19 patients with long-term olfactory dysfunction.
Lechien JR; Le Bon SD; Saussez S
Eur Arch Otorhinolaryngol; 2023 May; 280(5):2351-2358. PubMed ID: 36520209
[TBL] [Abstract][Full Text] [Related]
19. Remote psychophysical testing of smell in patients with persistent olfactory dysfunction after COVID-19.
Martončíková M; Doležal P; Fabianová K; Karhánek M; Gálik J; Raček A; Popovičová A; Račeková E
Sci Rep; 2023 Aug; 13(1):14090. PubMed ID: 37640847
[TBL] [Abstract][Full Text] [Related]
20. Parosmia is Associated with Relevant Olfactory Recovery After Olfactory Training.
Liu DT; Sabha M; Damm M; Philpott C; Oleszkiewicz A; Hähner A; Hummel T
Laryngoscope; 2021 Mar; 131(3):618-623. PubMed ID: 33210732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
